Expression of BMI-1 and Mel-18 in breast tissue - a diagnostic marker in patients with breast cancer

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Riis, Margit L H ^a   Lüders, Torben ^a   Nesbakken, Anne Jorunn ^a   Vollan, Hilde S ^a   Kristensen, Vessela ^a   Bukholm, Ida R K ^a,b  

^a AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BMI1 PROTEIN; MESSENGER RNA; PROTEIN MEL 18; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; BMI1 PROTEIN, HUMAN; NUCLEAR PROTEIN; ONCOPROTEIN; PCGF2 PROTEIN, HUMAN; REPRESSOR PROTEIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BMI 1 GENE; BREAST CANCER; BREAST EPITHELIUM; BREAST RECONSTRUCTION; CANCER DIAGNOSIS; CONTROLLED STUDY; DISEASE MARKER; FEMALE; GENE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; MEL 18 GENE; PROTEIN EXPRESSION; UPREGULATION; BREAST TUMOR; CHEMISTRY; DNA MICROARRAY; DOWN REGULATION; GENE EXPRESSION PROFILING; GENETICS; IMMUNOHISTOCHEMISTRY; METHODOLOGY; MIDDLE AGED; NORWAY; PATHOLOGY; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RISK FACTOR;

ADULT; AGED; BREAST NEOPLASMS; DOWN-REGULATION; FEMALE; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NORWAY; NUCLEAR PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RISK FACTORS; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION; YOUNG ADULT;

EID: 78650124273     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-686     Document Type: Article

References (30)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55:74-108. 10.3322/canjclin.55.2.74, 15761078.
2. Paajanen H, Kyhala L, Varjo R, Rantala S. Effect of screening mammography on the surgery of breast cancer in Finland: a population-based analysis during the years 1985-2004. Am Surg 2006, 72:167-171.
3. Weigel S, Batzler WU, Decker T, Hense HW, Heindel W. First epidemiological analysis of breast cancer incidence and tumor characteristics after implementation of population-based digital mammography screening. Rofo 2009, 181:1144-1150.
4. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001, 414:105-111. 10.1038/35102167, 11689955.
5. Sparmann A, van LM. Polycomb silencers control cell fate, development and cancer. Nat Rev Cancer 2006, 6:846-856. 10.1038/nrc1991, 17060944.
6. Park, Morrison, Clarke. Bmi1, stem cells, and senescence regulation. J Clin Invest 2004, 113:175-179. 311443, 14722607.
7. Kim JH, Yoon SY, Jeong SH, Kim SY, Moon SK, Joo JH, Lee Y, Choe IS, Kim JW. Overexpression of Bmi-1 oncoprotein correlates with axillary lymph node metastases in invasive ductal breast cancer. Breast 2004, 13:383-388. 10.1016/j.breast.2004.02.010, 15454193.
8. Liu S, Dontu G, Mantle ID, Patel S, Ahn NS, Jackson KW, Suri P, Wicha MS. Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res 2006, 66:6063-6071. 10.1158/0008-5472.CAN-06-0054, 16778178.
9. van Kemenade FJ, Raaphorst FM, Blokzijl T, Fieret E, Hamer KM, Satijn DP, Otte AP, Meijer CJ. Coexpression of BMI-1 and EZH2 polycomb-group proteins is associated with cycling cells and degree of malignancy in B-cell non-Hodgkin lymphoma. Blood 2001, 97:3896-3901. 10.1182/blood.V97.12.3896, 11389032.
10. Lindstrom MS, Klangby U, Wiman KG. p14ARF homozygous deletion or MDM2 overexpression in Burkitt lymphoma lines carrying wild type p53. Oncogene 2001, 20:2171-2177. 10.1038/sj.onc.1204303, 11360201.
11. Bea S, Tort F, Pinyol M, Puig X, Hernandez L, Hernandez S, Fernandez PL, van LM, Colomer D, Campo E. BMI-1 gene amplification and overexpression in hematological malignancies occur mainly in mantle cell lymphomas. Cancer Res 2001, 61:2409-2412.
12. Vonlanthen S, Heighway J, Altermatt HJ, Gugger M, Kappeler A, Borner MM, van LM, Betticher DC. The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression. Br J Cancer 2001, 84:1372-1376. 10.1054/bjoc.2001.1791, 2363629, 11355949.
13. van Kemenade FJ, Raaphorst FM, Blokzijl T, Fieret E, Hamer KM, Satijn DP, Otte AP, Meijer CJ. Coexpression of BMI-1 and EZH2 polycomb-group proteins is associated with cycling cells and degree of malignancy in B-cell non-Hodgkin lymphoma. Blood 2001, 97:3896-3901. 10.1182/blood.V97.12.3896, 11389032.
14. Alkema MJ, Jacobs H, van Lohuizen M, Berns A. Perturbation of B and T cell development and predisposition to lymphomagenesis in eu-Bmi1 transgenic mice require the Bmi1 RING finger. Oncogene 1997, 15:899-910. 10.1038/sj.onc.1201262, 9285685.
15. Itahana K, Zou Y, Itahana Y, Martinez JL, Beausejour C, Jacobs JJ, van LM, Band V, Campisi J, Dimri GP. Control of the replicative life span of human fibroblasts by p16 and the polycomb protein Bmi-1. Mol Cell Biol 2003, 23:389-401. 10.1128/MCB.23.1.389-401.2003, 140680, 12482990.
16. Dimri GP. What has senescence got to do with cancer?. Cancer Cell 2005, 7:505-512. 10.1016/j.ccr.2005.05.025, 1769521, 15950900.
17. Guo WJ, Datta S, Band V, Dimri GP. Mel-18, a polycomb group protein, regulates cell proliferation and senescence via transcriptional repression of Bmi-1 and c-Myc oncoproteins. Mol Biol Cell 2007, 18:536-546. 10.1091/mbc.E06-05-0447, 1783768, 17151361.
18. Dimri GP, Martinez JL, Jacobs JJ, Keblusek P, Itahana K, van LM, Campisi J, Wazer DE, Band V. The Bmi-1 oncogene induces telomerase activity and immortalizes human mammary epithelial cells. Cancer Res 2002, 62:4736-4745.
19. Silva J, Garcia V, Garcia JM, Pena C, Dominguez G, Diaz R, Lorenzo Y, Hurtado A, Sanchez A, Bonilla F. Circulating Bmi-1 mRNA as a possible prognostic factor for advanced breast cancer patients. Breast Cancer Res 2007, 9:R55. 10.1186/bcr1760, 2206731, 17711569.
20. Guo WJ, Zeng MS, Yadav A, Song LB, Guo BH, Band V, Dimri GP. Mel-18 acts as a tumor suppressor by repressing Bmi-1 expression and down-regulating Akt activity in breast cancer cells. Cancer Res 2007, 67:5083-5089. 10.1158/0008-5472.CAN-06-4368, 2386662, 17545584.
21. Tagawa M, Sakamoto T, Shigemoto K, Matsubara H, Tamura Y, Ito T, Nakamura I, Okitsu A, Imai K, Taniguchi M. Expression of novel DNA-binding protein with zinc finger structure in various tumor cells. J Biol Chem 1990, 265:20021-20026.
22. Dukers DF, van Galen JC, Giroth C, Jansen P, Sewalt RG, Otte AP, Kluin-Nelemans HC, Meijer CJ, Raaphorst FM. Unique polycomb gene expression pattern in Hodgkin's lymphoma and Hodgkin's lymphoma-derived cell lines. Am J Pathol 2004, 164:873-881. 1613333, 14982841.
23. Wei J, Kahn J. Purification of Total RNA from Mammalian Cells and Tissues. DNA Microarrays: A Molecular Cloning Manual 2002, 110-119. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press, Bowtell D, Sambrook J.
24. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004, 5:R80. 10.1186/gb-2004-5-10-r80, 545600, 15461798.
25. Bloom HJ, Richardson WW. Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 1957, 11:359-377. 2073885, 13499785.
26. Song LB, Zeng MS, Liao WT, Zhang L, Mo HY, Liu WL, Shao JY, Wu QL, Li MZ, Xia YF, et al. Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells. Cancer Res 2006, 66:6225-6232. 10.1158/0008-5472.CAN-06-0094, 16778197.
27. McNeill RE, Miller N, Kerin MJ. Evaluation and validation of candidate endogenous control genes for real-time quantitative PCR studies of breast cancer. BMC Mol Biol 2007, 8:107. 10.1186/1471-2199-8-107, 2211316, 18042273.
28. Tripathi A, King C, de la Morenas A, Perry VK, Burke B, Antoine GA, Hirsch EF, Kavanah M, Mendez J, Stone M, et al. Gene expression abnormalities in histologically normal breast epithelium of breast cancer patients. Int J Cancer 2008, 122:1557-1566. 10.1002/ijc.23267, 18058819.
29. Chen DT, Nasir A, Culhane A, Venkataramu C, Fulp W, Rubio R, Wang T, Agrawal D, McCarthy SM, Gruidl M, et al. Proliferative genes dominate malignancy-risk gene signature in histologically-normal breast tissue. Breast Cancer Res Treat 2010, 119:335-346. 10.1007/s10549-009-0344-y, 19266279.
30. Saeki M, Kobayashi D, Tsuji N, Kuribayashi K, Watanabe N. Diagnostic importance of overexpression of Bmi-1 mRNA in early breast cancers. Int J Oncol 2009, 35:511-515.